Testicular germ cell tumor (GCT) · line 2 · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Line of therapy | 2 |
|---|---|
| Track | transplant |
| Linked regimen | None |
| ID | IND-GCT-SALVAGE-2L-HDCT-ASCT |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-04 | pending_clinical_signoff |
| Diseases | DIS-TESTICULAR-GCT |
| Sources | SRC-EINHORN-HDCT-ASCT-2007 |
Used By
Algorithms
ALGO-GCT-METASTATIC-1L- ALGO-GCT-METASTATIC-1LALGO-GCT-SALVAGE-2L- ALGO-GCT-SALVAGE-2L
Indication
IND-GCT-SALVAGE-2L-TIP- IND-GCT-SALVAGE-2L-TIP